New Therapeutic Strategies Have Changed the Natural History of Pediatric Crohn’s Disease: A Two-Decade Population-Based Study

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.1K citations

Inflammation, Chronic Inflammatory Diseases, Anti-inflammatory +5

Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial

Jean–Frédéric Colombel, William J. Sandborn, Paul Rutgeerts et al. · Gastroenterology · 2006 · 2.2K citations

Chronic Inflammatory Diseases, Autoimmune Disease, Immunology +7

Pediatric modification of the Montreal classification for inflammatory bowel disease

Arie Levine, Anne M. Griffiths, James Markowitz et al. · Inflammatory Bowel Diseases · 2010 · 1.4K citations · Full text

Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children

Jeffrey S. Hyams, Wallace Crandall, Subra Kugathasan et al. · Gastroenterology · 2006 · 859 citations

Inflammation, Childhood Arthritis, Gastroenterology +5

Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence

Christopher M. Booth, Ian F. Tannock · British Journal of Cancer · 2014 · 461 citations · Full text